8-K filing — Adagio Medical Holdings, Inc. (ADGM)
Filed: 2026-11-05 AccNo: 0001104659-26-123074 Size: 213 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Adagio Medical Announces First Patient Treated In IDE Study Of Next-Generation vCLAS Ultra Ventricular Ablation System For Sustained Monomorphic Ventricular Tachycardia
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Crude Oil Gains 1%; Cintas Earnings Top Views
U.S. stocks fell Wednesday, led by a 1.1% Nasdaq drop. Cintas beat estimates and raised guidance; oil gained while gold, silver and copper declined.
Adagio Medical shares are trading lower after the company announced a strategic alternatives review and a workforce reduction.
Dow Falls 100 Points; General Mills Posts Upbeat Q1 Earnings
U.S. stocks fell Wednesday; General Mills beat estimates, energy rose, utilities declined, while oil gained and gold dropped.
Adagio Medical's Board Completes Strategic Review And Has Initiated A Formal Process To Explore Alternatives To Maximize Shareholder Value; May Include Acquisition, Merger, Business Combination, Or Other Transaction
Board of Directors has completed a comprehensive review of the Company's business, programs, resources and capabilities and has initiated a formal process to explore strategic alternatives focused on maximizing
Adagio Medical Holdings Q2 EPS $(0.30) Beats $(0.31) Estimate
Adagio Medical Holdings (NASDAQ:ADGM) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.31) by 3.23 percent. This is a 14.29 percent increase over losses of $(0.35) per